Pathology of flupirtine-induced liver injury:

Drug-induced liver injury may cause impairment of liver function and is a leading cause of acute liver failure. Identification of the causative substance in patients receiving several drugs is often difficult in clinical practice. Evaluation of liver biopsies in suspected drug-induced injury is a challenging task that requires close clinico-pathological correlation. Recognizing a characteristic morphological pattern of liver injury may contribute to identification of the causative drug. Flupirtine, a non-opioid analgesic, has been reported to cause liver injury of idiosyncratic type in rare instances. We wished to characterize the histopathological features of flupirtine-induced liver injury, which have not been reported so far. Liver biopsies of five patients with severe liver injury and one explanted liver of a patient with flupirtine-induced acute liver failure that required transplantation were assessed. In addition clinical presentation and course were reviewed and clinical follow up was performed. Extensive perivenular necrosis with associated ceroid pigment-laden macrophages and a mild to moderate lymphocytic infiltrate was a common feature in all cases. Histological extent of liver necrosis corresponded well to serum amino-transferase levels. Accidental reexposure of one patient resulted in a plasma cell rich hepatitis with perivenular necrosis. This study provides evidence that flupirtine can cause substantial liver injury of hepatocellular type. Liver damage is associated with a characteristic morphological picture, the recognition of which will aid in causality assessment of drug-induced liver injury. Clinical and histological features raise the possibility of an immune-mediated toxicity.

[1]  K. Ishak,et al.  Diclofenac‐associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions , 1995, Hepatology.

[2]  S. Kakar,et al.  Histological patterns in drug-induced liver disease , 2009, Journal of Clinical Pathology.

[3]  G. Danan,et al.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.

[4]  B. Terhaag,et al.  Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial* , 2008, Current medical research and opinion.

[5]  G. Niebch,et al.  [Pharmacokinetics and biotransformation of the analgesic flupirtine in humans]. , 1985, Arzneimittel-Forschung.

[6]  E. Björnsson,et al.  Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic , 2006, Alimentary pharmacology & therapeutics.

[7]  E. Wills,et al.  A morphologic study of unexplained hepatitis following halothane anesthesia. , 1978, The American journal of pathology.

[8]  J. Neuberger,et al.  Immune mechanisms in tienilic acid associated hepatotoxicity. , 1989, Gut.

[9]  R. N. Brogden,et al.  Mianserin: A Review of its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness , 1977, Drugs.

[10]  G. Kanel Histopathology of Drug-Induced Liver Disease , 2002 .

[11]  P. Watkins Drug-Induced Liver Injury Network , 2008, The American Journal of Gastroenterology.

[12]  J. Senior,et al.  Drug-related hepatotoxicity. , 2006, The New England journal of medicine.

[13]  S. Kakar,et al.  disease Histological patterns in drug-induced liver , 2009 .

[14]  R. Williams,et al.  Use of * Flupirtine Maleate as an Analgesic in Patients with Liver Disease , 1985, The British journal of clinical practice.

[15]  Neil Kaplowitz,et al.  Drug-Induced Liver Disease , 2002 .

[16]  R. Fontana,et al.  Standardization of nomenclature and causality assessment in drug‐induced liver injury: Summary of a clinical research workshop , 2010, Hepatology.

[17]  D. Kleiner,et al.  The Pathology of Drug-Induced Liver Injury , 2009, Seminars in liver disease.

[18]  U. Schwabe,et al.  Arzneiverordnungs-Report 2009 , 2009 .

[19]  H. Dalton,et al.  Antibiotic therapy: a major cause of drug-induced jaundice in southwest England , 2007, European journal of gastroenterology & hepatology.

[20]  A. Fitton,et al.  Flupirtine , 1993, Drugs.

[21]  K. Ishak,et al.  Ticrynafen‐Associated Hepatic Injury: Analysis of 340 Cases , 1984, Hepatology.

[22]  N. Chalasani,et al.  Epidemiology of idiosyncratic drug-induced liver injury. , 2009, Seminars in liver disease.

[23]  D. Seehofer,et al.  Flupirtine-induced hepatic failure requiring orthotopic liver transplant. , 2011, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[24]  Munir Pirmohamed,et al.  Fortnightly review: Adverse drug reactions , 1998 .

[25]  J. Hoofnagle,et al.  Drug‐induced liver injury network (DILIN) , 2004, Hepatology.

[26]  F. Klion,et al.  Hepatitis after exposure to halothane. , 1971, Annals of internal medicine.

[27]  M. Maschke,et al.  Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound , 2009, Expert opinion on pharmacotherapy.

[28]  N. Kaplowitz,et al.  Drug-Induced Liver Disease, Second Edition , 2002 .

[29]  C. Goodchild,et al.  Combination therapy with flupirtine and opioid: open-label case series in the treatment of neuropathic pain associated with cancer. , 2008, Pain medicine.

[30]  R. Barr,et al.  Diclofenac induced hepatitis , 1993, Digestive diseases and sciences.

[31]  R. Pothmann,et al.  Akutbehandlung des episodischen kindlichen Spannungskopfschmerzes mit Flupirtin und Paracetamol , 2000, Der Schmerz.

[32]  D. Shefet,et al.  Arzneimittelkommission der deutschen Ärzteschaft , 2006 .

[33]  K. Ishak,et al.  The morphologic spectrum of halothane‐induced hepatic injury: Analysis of 77 cases , 1985, Hepatology.